Dr Eulade Rugengamanzi delves into the topic of multiple myeloma, a malignant disease marked by an excess of SMMA cells in the bone marrow. He explores its incidence, risk factors, signs and symptoms, pathophysiology, diagnostic investigations, and treatment options.